FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1177-1179 September 18, 2003 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Crowther, M. A. PubMed Citation

Two decades after the presence of anticardiolipin antibodies and a syndrome of spontaneous thrombosis and fetal death were linked,¹ and after the publication of approximately 3500 reports in which the term "antiphospholipid syndrome" has been used, we still lack scientifically robust, evidence-based rules for the treatment of the antiphospholipid syndrome. This failure is due in part to a lack of well-designed prospective studies and in part to the clinical complexity of the syndrome. The complexity stems in part from the fact that the antiphospholipid syndrome actually comprises two syndromes, one that is not associated with another illness (primary antiphospholipid syndrome), . . . [Full Text of this Article]

Source Information

From the Hospital for Special Surgery, Joan and Sanford Weill College of Medicine of Cornell University, New York.

This article has been cited by other articles:

• Wu, H., Birmingham, D. J., Rovin, B., Hackshaw, K. V., Haddad, N., Haden, D., Yu, C.-Y., Hebert, L. A. (2008). D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus. CJASN 3: 1628-1636 [Abstract] [Full Text]  
• Roach, E. S., Golomb, M. R., Adams, R., Biller, J., Daniels, S., deVeber, G., Ferriero, D., Jones, B. V., Kirkham, F. J., Scott, R. M., Smith, E. R. (2008). Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39: 2644-2691 [Abstract] [Full Text]  
• Ruckert, A, Glimm, H, Lubbert, M, Grullich, C (2008). Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up. Lupus 17: 757-760 [Abstract]  
• Tarr, T, Lakos, G, Bhattoa, H P, Shoenfeld, Y, Szegedi, G, Kiss, E (2007). Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 16: 39-45 [Abstract]  
• Quenby, S., Farquharson, R.G., Dawood, F., Hughes, A.M., Topping, J. (2005). Recurrent miscarriage and long-term thrombosis risk: a case-control study. Hum Reprod 20: 1729-1732 [Abstract] [Full Text]  
• (2003). Antiphospholipid Antibody Syndrome: Is High-Intensity Warfarin Necessary?. JWatch General 2003: 2-2 [Full Text]